Achmea Investment Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.2M | Buy |
234,655
+34,600
| +17% | +$3.72M | 0.33% | 82 |
|
|
2025
Q1 | $20.2M | Buy |
200,055
+59,682
| +43% | +$6.02M | 0.29% | 102 |
|
|
2024
Q4 | $12.5M | Buy |
140,373
+67,362
| +92% | +$6.02M | 0.21% | 132 |
|
|
2024
Q3 | $6.12M | Buy |
73,011
+9,431
| +15% | +$790K | 0.1% | 207 |
|
|
2024
Q2 | $4.9M | Hold |
63,580
| – | – | 0.09% | 216 |
|
|
2024
Q1 | $4.36M | Hold |
63,580
| – | – | 0.08% | 237 |
|
|
2023
Q4 | $3.68M | Hold |
63,580
| – | – | 0.08% | 253 |
|
|
2023
Q3 | $3.36M | Buy |
63,580
+8,259
| +15% | +$436K | 0.07% | 254 |
|
|
2023
Q2 | $2.99M | Buy |
55,321
+38,141
| +222% | +$2.06M | 0.06% | 293 |
|
|
2023
Q1 | $859K | Hold |
17,180
| – | – | 0.02% | 406 |
|
|
2022
Q4 | $745K | Hold |
17,180
| – | – | 0.03% | 437 |
|
|
2022
Q3 | $665K | Hold |
17,180
| – | – | 0.02% | 449 |
|
|
2022
Q2 | $640K | Hold |
17,180
| – | – | 0.02% | 463 |
|
|
2022
Q1 | $761K | Hold |
17,180
| – | – | 0.02% | 483 |
|
|
2021
Q4 | $730K | Hold |
17,180
| – | – | 0.03% | 276 |
|
|
2021
Q3 | $745K | Buy |
+17,180
| New | +$745K | 0.02% | 475 |
|
|
2019
Q1 | – | Sell |
-12,216
| Closed | -$432K | – | 435 |
|
|
2018
Q4 | $432K | Buy |
+12,216
| New | +$432K | 0.02% | 395 |
|